Ignite Creation Date:
2024-05-06 @ 7:59 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06201234
Status:
RECRUITING
Last Update Posted:
2024-01-11
First Post:
2023-12-07
Brief Title:
Evaluating the Addition of Elacestrant Oral SERD to Olaparib PARP-inhibitor in Patients With AdvancedMetastatic HRHER2- Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group